SIRT1 and osteoporosis: Whether these STACs or other STACs inhibit osteoclast-mediated bone resorption or influence other Sirtuins in vivo remains to be investigated in disease models of osteoporosis, aging and impaired metabolism as these conditions are associated with reduced Sirt1 level and function [46,47].